samedan logo
 
 
 
spacer
home > pmps > winter 2001 > fine foods - a new style of subcontracting
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Fine Foods - A New Style of Subcontracting

Q What is meant by Fine Foods' 'new style'?

A Fine Foods (a pure subcontractor) proposes itself to have two categories of clients - pharmaceuticals and dietetic - supplying all the structures, competence and flexibility necessary to project manage and manufacture dietetic and pharmaceutical products.

The original strategic decisions of the company and its human resources have created a winning formula which is reflected in the continuing growth of Fine Foods

Q To help our readers better understand the structure of your company, can you give a brief history of Fine Foods?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rebecca Cavalфt of PMPS speaks to Marco Eigenmann, Managing Director of Fine Foods in Italy
spacer
Rebecca Cavalфt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center

Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020: Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed today a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston, MA.
More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement